 who underwent hematopoietic cell transplantation, that's HCT. Dr. Lucy Turcotte says their findings show the striking biological impact of social disadvantage and how it can alter health outcomes. When you have cells from a donor of low socioeconomic status, it leads to reduced survival by about 10%.